Bruush Oral Care Inc.
BRSHF · OTC
4/30/2023 | 10/31/2022 | 7/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | -58.8% | 8% | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 |
| % Margin | 75.6% | -25.2% | 30% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 |
| % Margin | -488.6% | -676.2% | -110.4% |
| Other Income/Exp. Net | $0 | $0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | -145.9% | -79.3% | -176.9% |
| EPS | -0.95 | -1.92 | -8.29 |
| % Growth | 50.5% | 76.8% | – |
| EPS Diluted | -0.95 | -1.92 | -8.29 |
| Weighted Avg Shares Out | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 |
| % Margin | -78% | -84.2% | -124.4% |